• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Charts / Financials

5.56% ! 17.0¢
Market Cap $38.41M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

refresh Created with Sketch. REFRESH
Day
Open 17.0¢   Day High 17.0¢   Day Low 16.5¢
Daily Volume 127049
Bids   Sellers
Number Price Volume   Number Price Volume
9 16.5¢ 425750   3 18.0¢ 90178

Directors & Senior Management

Dr. Kilian Kelly Chief Executive Officer, Managing Director, Director
Dr. Suzanne Lipe Vice President - Partner Engagement
Dr. Jolanta Airey Chief Medical Officer
Dr. Mathias Kroll Chief Business Officer
Mr. Peter Gordon Webse Company Secretary
Dr. Geoffrey E. D. Brooke Independent Non-Executive Chairman of the Board
Ms. Janine Rolfe Director
Dr. Darryl Maher Non-Executive Independent Director
Dr. Paul K. Wotton Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
17.0¢ 		Change
-0.010(5.56%) 		Mkt cap ! $38.41M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $21.40K 127.0K

Buyers (Bids)

No. Vol. Price($)
9 425750 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 90178 3
View Market Depth
Last trade - 14.06pm 13/06/2025 (20 minute delay) ?

Top Stories

ASX Ltd notches upward on sale of company meant to fix CHESS 3 years ago

ASX Ltd (ASX:ASX) has notched fractional gains in early Friday trades on the news it's ditched its shareholdings in...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing) Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Iberian expansion: Megado turns to Europe with Spanish copper mines Megado Minerals has added the Iberian Copper Project in Spain to its expanding collection after buying an 80% interest in Iberian Copper.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.